Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence DUBLIN - December 17, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug ...
The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive ...
Medtronic reported that the FDA approved the InterStim smart programmer, an app-based platform that assists patients in the long-term management of therapy for overactive bladder or chronic fecal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback